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ABSTRACT
In Escherichia coli, growth is rate-limited by translation capacity [1]. Stalled
ribosomes have profound effects on a cell such as altered mRNA abundance, decreased
ribosome availability, and an imbalanced proteome. The absence of elongation factor P
(EF-P), a universally conserved transpeptidation enhancer, presents an extreme example of
this scenario, wherein ribosomes accumulate disproportionately onto messages that are
more slowly translated and cell growth becomes notably impaired. We discovered that
faster-growing cells arise spontaneously in Δefp cultures, suggesting that translation
defects could be circumvented by mutating other genes. This thesis presents a genetic and
biochemical analysis of a mechanism Δefp cells employ to overcome translation stress.
Using a dual luciferase reporter system, we found that transpeptidation
remained hindered in the faster growing Δefp cells. Whole genome sequencing of several
fast-growing strains revealed mutations in a poorly characterized RNA helicase called
HrpA. We determined that deletion of hrpA, or mutations at several conserved residues
critical for HrpA’s function, was sufficient to improve the fitness of Δefp cells.
HrpA is a DEAH-box RNA helicase and represents a large class of
enigmatic proteins that use ATP to restructure cellular RNAs; however, it’s direct function
in cellular physiology has yet to be clearly demonstrated [2, 3]. Several HrpA mutants were
engineered to interrogate the molecular mechanism of HrpA and how its function impairs
Δefp cells. Complementation in Δefp ΔhrpA cells showed that a number of these mutants
were unable to restore sickness, suggesting they were defective in key aspects of RNA
processing. It was discovered that wild-type HrpA is associated with actively translating
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ribosomes and several of the inactive HrpA mutants impose substantial deleterious effects
on translation and ribosome production.
In sum, the work presented here describes a mechanism by which cells overcome
translation stress involving a novel genetic and biochemical relationship between EF-P and
HrpA.
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CHAPTER 1: INTRODUCTION

Preface

This chapter was composed entirely by R.J.W. Comments from S.D.M. were incorporated
into the final version presented here.

Elongation factor P is a transpeptidation enhancer

Elongation factor P (EF-P) is a universally conserved transpeptidation enhancer
that binds to ribosomes and interacts with the peptidyl transferase center to stimulate
peptide bond formation, mainly in the translation of polyproline motifs. EF-P is highly
similar to tRNAs in both size and shape, and binds to the ribosome between the P and E
site [4]. While not essential for viability in Escherichia coli, cells lacking EF-P suffer from
several deleterious physiological effects [5].
EF-P interacts with ribosomes using several conserved residues. The most vital for
its function is a highly conserved lysine residue at position 34, whose post-translational
modification is essential for the molecular mechanism of EF-P [6-8]. A series of three
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proteins are responsible for the post-translational modification of EF-P; EpmA, EpmB, and
EpmC. EpmB is a lyine 2,3-aminomutase that converts α-lysine to β-lysine which is then
added to Lys34 of EF-P by the lysyltransferase EpmA [6, 8]. EpmC coordinates the final
step in the post-translational modification of EF-P by hydroxylation of Lys34 of EF-P [9].
During translation of a polyproline motif, steric constraints of consecutive prolines result
in the peptidyl-tRNA becoming destabilized, leading to reduced accommodation for an
aminoacyl-tRNA in the ribosomal A-site [4]. The post-translationally modified residue of
EF-P functions in alleviation of polyproline mediated ribosomal pausing by stabilizing the
CCA end of the peptidyl-tRNA [4].
The first reports on the function of EF-P demonstrated its involvement in the
formation of the first peptide bond during translation [10, 11]. Later investigations utilized
crystal structures to show that EF-P helps to correctly position fMET-tRNAfMET, the
initiator tRNA, during translation initiation [12]. Within the last decade, a wealth of
knowledge has been gained in regards to EF-P’s role in the cell and the molecular
mechanism behind its function. A more extensive look at the mechanism of EF-P revealed
that its stimulatory influence on peptidyl transfer was more specific to the amino acid
proline [13]. Proline is both a poor donor and acceptor during peptide bond formation due
to its structural difference from the other 19 amino acids. The R group constituent of proline
is a five-membered cyclic ring that imposes a rigid, less flexible structure, reducing phi
and psi angles of the amino acid which can result in cumbersome positioning for residues
critical for transpeptidation. Moreover, the cyclic side chain of proline is bond to the
nitrogen nucleophile that is involved in formation of the peptide bond during translation
[14, 15].
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Ribosomal pausing at proline residues was originally shown to occur at motifs
consisting of three or more residues, but recent reports using ribosome profiling studies in
cells lacking EF-P demonstrated that diprolyl sequences are sufficient for pausing, and that
the amino acid context surrounding the diprolyl sequence can either intensify or alleviate
the strength of the stall [16-19]. In support of the contextual influence of surrounding
residues is the fact that only a small percentage of diprolyl sequences result in ribosomal
pausing in cells lacking EF-P [19]. Ribosome profiling studies revealed that when a proline,
glycine, or aspartate before a diprolyl sequence, and tyrosine, asparagine, or aspartate
following a diprolyl sequence result in strong ribosome stalling and a substrate for EF-P
[17]. However, ribosomal stalling at polyproline motifs is not a traditional stall
characteristic of being acted upon by ribosome rescue systems [20]. One such stall that
requires ribosome rescue is a non-stop mRNA, transcripts that are lacking stop codons.
With non-stop mRNAs, ribosomes reach the end of a transcript during translation and are
unable to terminate. This type of stall has a hallmark rescue system involving a specialized
hybrid tRNA/mRNA, called tmRNA, that allows for completion of termination,
degradation of the peptide, and recycling of the stalled ribosome. In the case of stalling at
polyprolines, it is only the slow chemical reaction kinetics of peptidyl transfer involving
proline that are at fault for the stalling, meaning that the stall is only transient and
translation elongation will resume. Despite polyproline stalls being transient and only
approximately 100 genes encoding polyproline motifs in E. coli, the loss of EF-P has
substantial pleiotropic effects on cellular physiology including altered proteomes,
compromised outer membranes, and diminished virulence [18, 21, 22].
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The extensive investigations and knowledge gained over the last decade into the
role of EF-P in the cell and its molecular mechanism has been substantial, however, there
is still much to learn about this protein in other organisms. For instance, in Bacillus subtilis,
the post-translational modification of EF-P is different than that in E. coli, has a limited
impact on polyproline translation, and has a broad influence on swarming [23, 24].
Additionally, a recent study on the cellular distribution of EF-P indicated that EF-P is
present on ribosomes at a frequency greater than the number of pausing events [25, 26].
This observation suggests that, in addition to alleviating ribosome pausing at polyproline
motifs, EF-P may be tasked with evaluating overall translation or ribosome integrity by
binding between the ribosomes E- P-sites.

An introduction to HrpA and other RNA helicases

RNA helicases are enzymes that utilize the energy from nucleoside triphosphate
(NTP) hydrolysis to participate in all levels of RNA metabolism and are ubiquitous
throughout nature [27]. They are structurally and mechanistically similar to DNA helicases
and other ATP utilizing enzymes [28]. Two main classes of helicases exist: one whose
members form multimeric ring-like structures and the other whose members act as
monomers [29]. These two classes are comprised of six Super Families and members are
further differentiated into subfamilies based on sequence and structural features. In
Escherichia coli, hrpA is one of the largest genes and is a member of the DEAH/RHA
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subfamily of Super Family 2 (SF2) RNA helicases. RNA helicase involvement in cellular
physiology is extensive, ranging from regulation of transcription, mRNA processing and
decay, to translation initiation and regulation [2, 3, 27, 30-40]. A number of infections and
diseases have been shown to be directly linked to RNA helicase involvement, and targeting
either host or pathogen RNA helicases has been proposed as promising therapeutic targets
with promising results (Table 1-1) [41-43].
A group of classical DEAH-box RNA helicases are the PRP helicases from
Saccharomyces cerevisiae, specifically PRP2, PRP16, PRP22, and PRP43. These proteins
have been shown to be involved in multiple levels of pre-mRNA splicing, a mechanism of
mRNA maturation that occurs prior to translation and essential for correct protein
expression, and bear strong homology to HrpA [44-47]. These proteins function as RNA
chaperones, responsible for the correct structural manipulation of precursor mRNAs, as
dissociation motors that disrupt RNA-protein interactions, or as proofreaders that ensure
correct splicing of mRNA substrates [47]. ATP hydrolysis powers the mechanical function
of these enzymes and mutations that compromise ATPase activity result in dominantnegative phenotypes [47]. Eight RNA helicases in total act in an orchestrated manner to
facilitate optimal splicing of precursor mRNA in S. cerevisiae [48].
All known RNA helicases are NTPases with phosphate binding loops (P-loops),
also known as a Walker A motif. Walker A motifs stabilize the β-phosphate of bound NTP
molecules by direct interaction, as well as indirectly by coordination of a magnesium ion
[49, 50]. The Walker A motif constitutes motif I in SF2 RNA helicases and hrpA. Situated
downstream of the Walker A motif is the Walker B motif, assisting in coordination of the
magnesium ion and critical for NTP hydrolysis. The Walker B motif is motif II. An
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aspartate and a glutamate residue are the hallmarks of this motif; the aspartate residue
assists in coordination of a magnesium ion that stabilizes the β- and γ-phosphates, and the
glutamate residue is responsible for directing a water molecule involved in the hydrolysis
of the γ-phosphate [49, 51]. While these two motifs constitute the energy production
necessary for the function of RNA helicases, they are part of a larger domain architecture
that helps to categorize this class of enzymes.
The domain organization present in hrpA sequence alignments is consistent with
other SF2 DEAH/RHA subfamily RNA helicases and within this architecture are motifs
that are classified as participating in either NTP hydrolysis, NTP hydrolysis sensing, or
oligonucleotide binding. HrpA, like other SF2 DEAH/RHA subfamily RNA helicases,
contains a helicase core region where two highly conserved helicase domains separated by
a short linker region reside. These two helicase domains fold in a stacked manner that forms
a pocket with binding region for both NTPs and RNA; the RNA substrate is bound towards
the outer edge of the two domains, or the top of the pocket, and NTP binding and hydrolysis
located down inside the pocket [29, 52]. In between the NTP binding/hydrolyzing and
substrate binding motifs is motif III, serving to link the energy from NTP hydrolysis to
mechanical helicase function [29, 38, 53]. Additional motifs outside of those mentioned
vary considerably in their sequence, however, their spatial arrangement maintains a
moderate level of conservation. This could be an indication that the spatial arrangement is
necessary for the function of this class of enzymes, but the sequence differences allows for
their targeted substrates to vary [27, 54]. The lack of substrate sequence specificity could
possibly indicate that a substrate must be presented in a conformation that stimulates
activity or co-factors are required for substrate recognition. Furthermore, substrate binding
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seems to be accomplished by interactions with the sugar-phosphate backbone of nucleic
acid, owing to the distinction between DNA and RNA substrates considering the hydroxyl
group on the 2’ carbon of RNA bases. Interactions only with the backbone of a nucleic acid
substrate limits the strength of binding, whereas interactions with specific bases of
substrates would yield stronger binding and limit the ability to dissociate double stranded
molecules [54].
Outside of the conserved helicase core are N- and C-terminal extensions that are
highly variable and are believed to dictate the various functions of each protein. For
instance, these extensions may be able to promote added substrate specificity through
interrogating substrate conformation, act as recruitment sites for co-factors, or designate
cellular localization. In HrpA, for example, the C-terminal half of the protein consists of a
region that bears slight homology to ribosomal protein bS1, however this domain has no
known function and is classified as domain of unknown function 3418 (DUF3418) [44].
Escherichia coli has eight genes that encode for RNA helicases, two of which are DEAHbox RNA helicases: HrpA and HrpB. Sequence alignment of these two proteins show
strong homology in motifs conserved in other DEAH-box RNA helicases, but a role in
cellular physiology for each of these proteins has yet to be established. HrpA is one of the
largest proteins, 149 kilodaltons, in E. coli, almost twice the size of HrpB. Much of this
size is owed to the large C-terminal domain of HrpA. It is believed that a major determinant
of HrpA’s physiological role is that of the DUF3418 C-terminal domain.
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Previous studies on HrpA

To date, there has not been a clear demonstration of HrpA’s role in the cell.
Previous studies on HrpA have shed some light on its involvement in cellular physiology,
but a clear mechanistic understanding is still lacking. ATP hydrolysis activity, stimulation
of its ATPase activity using poly-adenosine RNA, and helicase activity for the HrpA
ortholog in Borrelia burgdorferi, the etiological agent of Lyme disease, has been
demonstrated [55, 56]. While each of these observations are a step towards characterizing
HrpA there are still caveats to these details. For instance, a characterization of HrpA’s in
vivo Michaelis-Menton kinetics has yet to be completed. Furthermore, stimulation of
ATPase activity with poly-adenosine RNA and unwinding of duplex RNA are hallmarks
of RNA helicases, in vitro activity does not necessarily indicate in vivo activity [38].
Analysis of sequence alignment between B. burgdorferi HrpA and E. coli HrpA reveals a
high level of conservation in motifs consisting of the helicase core region, however, the
DUF3418 C-domain of E. coli HrpA is absent in B. burgdorferi HrpA, which may indicate
substantially different substrate targets and activity within a cell. HrpA in B. burgdorferi
is essential for tick transmission and mouse infectivity, and an hrpA mutant exhibits
differential expression across a wide variety of proteins [56]. Given the breadth of proteins
affected by differential expression, there is no clear indication as to the role HrpA plays in
gene regulation, and a clear molecular mechanism of the loss of transmission and
infectivity is still absent.
In a clinical isolate of Escherichia coli isolated from a patient with persistent
diarrhea, HrpA was shown to be involved in the cleavage of a polycistronic mRNA
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transcript, the daa operon [2]. The transcript encodes proteins that are structural
components of a fimbrae implicated in attachment during colonization. Construction a
large structure, such as a fimbrae, is an expensive endeavor for a cell in terms of energy
and resources, therefore, optimal expression of key components its necessary. The cleavage
of the transcript allows for differential expression of components necessary for efficient
biogenesis of the fimbrae. HrpA was identified as a factor involved in the cleavage of the
daa operon to tailor the expression of fimbrae components, and several HrpA mutants were
unable to complement the processing event [2]. Moreover, the processing of the transcript
was never fully abolished with any of the mutants employed indicating that either HrpA’s
activity overlaps with another RNA helicase within the cell, or that HrpA does not directly
participate in the cleavage event. Curiously, it was observed that the cleavage site was
upstream of a diprolyl sequence. Cleavage of the transcript occurred at a fixed distance
from ribosomes with the diprolyl motif in the P- and A-site and was not sequence
dependent.
In a study investigating the proteome of Escherichia coli cells lacking efp, the two
biological replicates derived from Δefp cells had different proteomic patterns [18]. HrpA
was one of the proteins with a large difference between the two samples, suggesting fastgrowing Δefp suppressor mutant generation and that downregulation, or even deletion, of
HrpA in fast-grower suppressor mutants is a common theme for overcoming Δefp sickness.
With this in mind, it is very possible that much of the physiological studies on Δefp cells
may have been skewed by the generation of fast-growing suppressor mutants and should
be a consideration when developing experiments involving cells lacking EF-P.
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Figures
Table 1-1: Diseases and infections with RNA helicase involvement
Disease/Infection
HIV/HIV-1

RNA helicase
DDX1, 3, 5, 6, 17,
21, 24, 47

Vaccinia virus
infection
viral infections

NPH-II

Chagas disease
Chronic gastritis,
gastric ulcers
Lyme disease
Cyptococcosis
Senataxin

Spinocerebellar ataxia
Alzheimer disease
Neuroblastoma,
retinoblastoma
Colorectal, prostate,
and breast cancer
Lung and
gastrointestinal cancer
Melanoma; liver, lung,
colon, and breast
cancer
Aging, cancer

NS3 helicases, RIGI like receptors
HelTc
DeaD
HrpA
Vad1
Amyotrophic lateral
sclerosis, ataxiaoculomotor apraxia
DDX6
UAP56
DDX1
DDX5/p68
DDX39

Physiological role
Nuclear export, splicing, virion
assembly, RNA trafficking, genome
packaging, retroviral replication
Vaccinia virus replication, viral gene
transcription
RNA virus replication, viral particle
assembly, viral RNA sensor, innate
antiviral immune response
T. cruzi cycle
H. pylori life cycle
B. burgdorferi life cycle
C. neoformans life cycle
Unknown

mRNA decay, P body assembly
Spliceosome assembly, mRNA
nuclear export
Transcription, mRNA processing,
translation
microRNA processing and maturation
Growth association, genome integrity
maintenance
Translation initiation

eIF4A

DHX36

Telomere maintenance, mRNA
degradation
Note: adapted from “RNA helicases in infection and disease” [54].

10

CHAPTER 2: HRPA EXACERBATES ΔEFP SICKNESS
PHENOTYPE IN ESCHERICHIA COLI

Preface

This chapter was composed entirely by R.J.W. Comments from S.D.M. were incorporated
into the final version presented here.

Introduction

In Escherichia coli, cells lacking elongation factor P (EF-P), a transpeptidation
enhancer conserved in bacteria, are plagued by defects in ribosome production, exhibit an
inefficient translation of poly-proline motifs, have an imbalanced proteome and
transcriptome, and grow notably slower than their parental wild-type strain. EF-P aids
ribosomes in the synthesis of difficult to translate motifs, most notably polyproline motifs
[17-19]. More recently, it has been proposed that EF-P aids ribosomes in translation of
other stall-prone peptide motifs and may also be a universal interrogator of translation
efficiency [25, 26]. Structural observations from cryo-electron microscopy data have
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demonstrated the long asserted notion that EF-P alleviates steric constraints within the
peptidyl transferase center of the ribosome during translation of polyproline motifs [4].
These data have also implicated several other residues of EF-P in interactions with other
moieties of the elongation complex [4]. Previous reports have demonstrated that in cells
lacking EF-P, only a small population of ribosomes are stalled at polyproline motifs,
suggesting that the sickness caused by the loss of EF-P is the result of other physiological
effects [19, 57].

Materials & Methods
Bacterial strains and plasmids
Strain SM1344 (BW30270, an fnr+, rph+ derivative of MG1655, with the rna open
reading frame [56] replaced by FLP recombination target [FRT] site) was used as wildtype (WT) E. coli for this study. The genes encoding hrpA and efp were deleted by
recominbeering in strain SM1036 (DY378, W3110 λcI857 Δ[cro-bioA]) using selection for
a FRT-flank kanamycin resistance gene with 25 μg/ml kanamycin [58]. Mutants of hrpA
and efp were P1 transduced into 1344 and the modifications verified by diagnostic PCR
and DNA sequencing [59, 60]. Removal of the kanamycin resistance gene (kanr) at both
hrpA and efp loci was performed using site specific recombination with plasmid pCP20.
pCP20 is a plasmid carrying both ampicillin and chloramphenicol resistance genes,
exhibits temperature sensitive replication, and expresses a yeast FLP recombinase required
for site specific recombination [61]. Kanr deletion mutants were transformed with pCP20
and ampicillin resistant transformants were selected at 30C with 150 μg/ml ampicillin.
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Four transformants of each deletion were restreaked on non-selective LB plates for
isolation and incubated at 37C to suppress pCP20 replication. Colonies were then streaked
to test for loss of resistance towards ampicillin and kanamycin.
For complementation, wild-type hrpA was PCR amplified from genomic DNA of
SM1344 using Q5 polymerase (New England Biolabs) and ligated into a derivative of the
pTrc99a plasmid [62].
For cloning of the dual luciferase reporter, Firefly luciferase and NanoLuc
luciferase were PCR amplified from plasmid constructs from Promega and ligated into a
derivative of the pTrc-99a plasmid. Addition of trypsin cut sites, a His6 epitope, and test
motif was performed with ‘Round the horn site directed mutagenesis.

Growth media and conditions
In general, all strains were grown in LB broth or on LB plates supplemented with
0.2% glycerol, 0.2% glucose, and appropriate antibiotic where needed.

Δefp suppressor mutant selection & isolation
For selection and isolation of Δefp faster-growing suppressor mutants, an initial
culture of efp::kan was grown overnight in 5 mls LB with 0.2% glycerol, 0.2% glucose,
and 25 μg/ml kanamycin at 37C. Next day, 10 μls of the overnight culture was streaked
for colony isolation alongside the parent efp::kan strain for comparison and 5 μls used as
a 1/1000 dilution for passaging in 5mls LB. This process was repeated until faster-growing
suppressor mutant colonies were visible on LB plates. Colonies of suppressor mutants were
freezer stocked in LB with 0.2% glucose and 12.5% glycerol, stored at -80C.
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Genomic DNA purification, genome sequencing, and analysis
Freezer stocked Δefp fast-growing suppressor mutants were re-streaked onto LB
plates with 0.2% glucose and 0.2% glycerol, and grown overnight at 30C. Colonies from
each plate were then aseptically transferred from plates and deposited into 1.7 ml
microfuge tubes. 200 μls of resuspension buffer (50 mM Tris-Cl, 10 mM EDTA pH 8.0
with 50 μg/ml RNaseA) was added and cells vortexed into solution. Approximately 100
μls of 0.1 mm zirconia disruption beads were added to resuspended cells. Cells were then
lysed 2X using an MP Biomdicals FastPrep-24 5G homogenizer at 10.0 m/sec for 1 minute.
500 μls of GuSCN buffer (5.5M guanidine thiocyanate, 0.1 M sodium acetate pH 5.0) was
added to lysed cells and insoluble cell debris pelleted for 5 minutes at 21,000 x g. The
resulting supernatant was then transferred to a fresh 1.7 ml microfuge tube, 100 μls of
100% isopropanol added, and tubes were vortexed to mix and briefly spun down in a bench
top mini-centrifuge to collect sample. Genomic DNA was then bound to EconoSpin Silica
Membrane Mini Spin columns, washed 3X with wash buffer (5 mM K +-HEPES, 20 mM
sodium chloride, 0.02 mM EDTA, 80% EtOH, pH 8.3) and eluted 2X with 50 μls of elution
buffer (5 mM Tris-Cl, 0.2 mM EDTA, pH 7.8). DNA concentration and purity was
measured by preparing 100-fold dilutions of eluted genomic DNA in fresh elution buffer
and measuring absorbance from 230 nm to 360 nm. Genomic DNA was diluted to 250
ng/μl for sequencing.

Preparation of polysomes
In general, overnight cultures of desired strains were grown in LB with 0.2%
glycerol, 0.2% glucose, with antibiotic selection if needed, at 30C. Overnight cultures
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were diluted 1/100 in LB with 0.2% glycerol, 0.2% glucose, and 10 mM sodium
bicarbonate and grown at 37C with shaking until cultures reached early exponential phase,
approximately 2 hours. Prior to harvest, buffered ice cubes were crushed, added to
centrifuge bottles, and placed in a -80C freezer. At time of harvest, cultures were rapidly
chilled by pouring over crushed buffered ice. Cells were collected by centrifugation at
12,000 x g for 2 minutes, washed with cell wash buffer (25 mM K +-HEPES, 150 mM
sodium chloride, 20 mM magnesium acetate, pH 7.5). After washing, cells were pelleted
by centrifugation at 12,000 x g for 2 minutes and resuspended in 750 μls HT-20 (25 mM
HEPES-Tris, 100 mM K+-glutamate, 20 mM magnesium acetate, 14 mM βmercaptoethanol, 0.05% Tween-20, pH 7.5). For lysis, 100 μls of 0.1 mm zirconia
disruption beads were added to resuspended cells and lysis performed using an MP MP
Biomdicals FastPrep-24 5G homogenizer at 10.0 m/sec for 30 seconds. Lysates were
clarified 2X by centrifugation at 18,000 x g for 15 minutes at 4C and lysates transferred
to fresh 1.7 ml microfuge tubes. Lysates were normalized by measuring the absorbance at
260 nm of a 1/100 dilution in 10 mM Bis-Tris pH 6.5.

Ultracentrifugation and polysome profiles
200 μl aliquots of cell lysates were layered onto 10-40% sucrose gradients prepared
with supplemented HT-20 using a gradient master (Biocomp) and centrifuged in an SW41 rotor [4] at 35,000 rpm (151,000 x g) for 3.5 hours at 4C. Polysome profiles were
generated during fractionation with a gradient fractionator (Biocomp).

15

Luciferase assays
Parent, ΔhrpA, Δefp, and ΔhrpA Δefp strains carrying either the dual luciferase
control or poly-proline reporter constructs were grown overnight in LB with 0.2% glycerol,
0.2% glucose, and 200 μg/ml ampicillin at 30C with shaking. Next day, overnights of each
strain were diluted 1/100 in LB with 0.2% glycerol and 200 μg/ml ampicillin and grown at
37C with shaking for 2 hours. Cultures were then induced with 0.5 mM IPTG for 30
minutes and then immediately placed on wet ice. 50 μls of each culture was loaded into a
black, clear bottom 96-well plate (Corning) in triplicate followed by addition of an equal
volume of ONE-Glo EX Reagent (Promega) and mixed by shaking for 5 minutes. Relative
firefly luciferase activity was determined by measuring photon emission in each well for
150 ms using a SpectraMax i3x Microplate Reader (Molecular Devices). To measure
NanoLuc luciferase activity, 50 μls of NanoDLR Stop & Glo Reagent (Promega) was
added to each well and mixed by shaking for 5 minutes and activity determined by
measuring photon emission in each well for 150 ms. Luciferase activity for each sample
was averaged and the value of an LB only control subtracted. NanoLuc luciferase activity
was divided by firefly luciferase to determine the ratio of ribosomes able to translate
through the test sequence between the upstream firefly luciferase gene and the downstream
NanoLuc luciferase gene. Values were normalized relative to the ‘Parent AST’ control.

Coomassie and western blotting
Parent, ΔhrpA, Δefp, and ΔhrpA Δefp cultures grown for luciferase assays were used
for SDS-PAGE for Coomassie staining and Western blotting. At time of harvest, 100 μls
of each culture was used to measure the optical density at 600 nm. Samples were
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normalized, harvested by centrifugation, and stored at -80C. Samples were removed from
the -80C freezer and cell pellets resuspended in 50 μls of SDS-PAGE sample buffer (100
mM Tris-Cl pH 8.5, 50 mM β-mercaptoethanol, 7% SDS, 0.1% bromophenol blue, 40%
glycerol) and boiled for 5 mins at 100C. 1.5 x 107 cells of each sample were loaded per
well on a 10 well, 12% acrylamide bis-Tris protein gel and run in 1X MOPS running buffer
(Boston Bioproducts) at 30 mA/gel for 90 minutes. Following electrophoresis, gels were
either stained with coomassie blue or transferred to PVDF membranes (Idea Scientific) and
blocked with 10% gelatin from cold water fish skin (Sigma) in blocking buffer (20 mM
K+-HEPES, 150 mM NaCl, , 0.05% Tween-20, 0.2 mM EDTA, pH 7.5). Monoclonal
mouse-anti-polyHistidine-Peroxidase (Sigma) (1:10,000) was used to probe for products
from expression of the dual luciferase reporter. Membranes were washed 3X prior to
imaging using a FlourChem E imager (Protein Simple).

Reporter purification and digestion
For preparation of peptides for mass spectrometry analysis, Parent, ΔhrpA, Δefp,
and ΔhrpA Δefp strains carrying either the dual luciferase control or poly-proline reporter
constructs were grown overnight in 7 mls of LB with 0.2% glycerol, 0.2% glucose, and
200 μg/ml ampicillin at 30C with shaking. Next day, overnights of each strain were diluted
1/100 in 500 mls of LB with 0.2% glycerol and 200 μg/ml ampicillin and grown at 37C
with shaking for 2 hours. Cultures were then induced with 0.5 mM IPTG for 30 minutes
and then immediately poured of crushed buffered ice for rapid chilling. Cells were
harvested by centrifugation at 12,000 x g for 3 minutes, cell pellets washed in 1/10 th the
culture volume of cell wash buffer (25 mM K+-HEPES, 150 mM NaCl, 1 mM EDTA, pH
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7.5), pelleted once again at 12,000 x g for 3 minutes, and cells resuspended in denaturing
nickel lysis and binding buffer (20 mM Tris-Cl, 500 mM NaCl, 6 M GuHCl, 14 mM βmercaptoethanol, 0.05% Tween-20, 2 mM imidazole, pH 8.5) and stored at -80C. Lysates
were thawed at room temperature and insoluble cell debris pelleted 2X at 18,000 x g for
10 minutes. Clarified lysates were transferred to new tubes and 250 μls of washed nickel
slurry (Thermo Scientific) was added to each lysate. Binding of the dual luciferase reporter
was performed at room temperature for 2 hours. Nickel resin was pelleted by centrifugation
at 2,000 x g for 1 min and transferred to 2 ml 0.45 μm Spin-X tube filters (Costar), washed
with wash buffer (20 mM Tris-Cl, 500 mM NaCl, 8 M urea, 10 mM imidazole, 14 mM βmercaptoethanol, 0.05% Tween-20, pH 8.5) and then eluted with elution buffer (125 mM
AcOH, 8 M urea). The pH of the elution samples was neutralized with 150 mM Tris.
For digestion of the purified dual luciferase reporter, 2 ng of Trypsin Gold
(Promega) was added to each elution sample and incubated overnight at 37C with shaking
for 16 hours. After digestion, samples were mixed with 5 mls of nickel binding buffer, 40
μls of washed nickel slurry added, and binding performed at room temperature for 2 hours.
Nickel resin was pelleted at 2,000 x g for 1 min and transferred to 2 ml 0.45 μm Spin-X
tube filters (Costar), rinsed with rinse buffer (20 mM Tris-Cl, 8 M urea, pH 8.5), and eluted
with elution buffer (125 mM AcOH, 8 M urea).

Mass spectrometry of purified and digested reporter
Trifluoroacetic acid (TFA) was added to digested and purified peptides to a final
concentration of 0.1%. Peptides were desalted and concentrated using μ-C18 ZipTips
(Millipore) and eluted in 5 μls of elution buffer (80% acetonitrile, 0.1% TFA). 0.5 μls of a
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saturated solution of α-cyano-4-hydroxycinnamic acid matrix (SIGMA) in 50%
acetonitrile and 0.1% TFA was spotted onto polished steel MALDI-ToF target plate and
allowed to air dry. 0.5-1 μl of desalted and concentrated sample was spotted on top of dried
matrix and allowed to air dry. An additional 0.5 μls of α-cyano-4-hydroxycinnamic acid
matrix was then added on top of dried sample and allowed to air dry. Mass spectra were
obtained using a Microflex MALDI-ToF mass spectrometer (Bruker) and data analyzed
using mMass software [63].

Results

Fast-growing Δefp suppressor mutants have an inactivated hrpA ORF
Cultures of cells lacking elongation factor P give rise to fast-growing suppressor
mutants (Figure 2-1). Genomic DNA from fast-growing Δefp suppressor mutants was
isolated for genome sequencing. Ethidium bromide gel electrophoresis indicated that
samples were free of RNA that may obfuscate downstream analysis (Figure 2-2). Analysis
of genome sequencing data revealed two classes of mutations, inactivating either the
second half of hrpA or disrupting the entire open-reading frame (orf) altogether (Figure 23). In one class of independently isolated mutants, sequencing data analysis revealed a
C→T transition resulting in a stop codon and an IS1B insertion element that inactivated
the second half of hrpA (Figure 2-3a). Three of the second class of independently isolated
mutants each had large genomic deletions, greater than 100 kb in each, containing the hrpA
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orf. Sixteen other fast-growing mutants were isolated during the second screen and several
attempts at PCR amplification of the hrpA orf using different primer sets was attempted,
however, none of the isolated mutants generated products, indicating the orf was disrupted.

Deletion of hrpA is sufficient to improve fitness of Δefp cells
Analysis of genome sequencing data revealed two classes of mutants with improved
fitness of Δefp cells involving the inactivation of hrpA via different mechanisms. To assess
whether deletion of the hrpA orf alone is sufficient to improve the health of Δefp cells, a
ΔhrpA allele was transduced into Δefp cells. Plating on solid LB media (Figure 2-4a) and
optical density measurements of liquid culture growth (Figure 2-4b) demonstrate that
inactivation of hrpA is sufficient to improve the health of Δefp cells, and that the recovered
mutants are loss of function mutants. Additionally, deletion of hrpA alone does not confer
a growth phenotype.
Polysome profiles of parent, ΔhrpA, Δefp, and Δefp ΔhrpA strains reveal findings
consistent with solid media plating and liquid growth measurements (Figure 2-5). Deletion
of hrpA alone imparts no growth phenotype when compared to the parent strain. The
absence of EF-P results in subunit maturation defects and impaired polysome formation,
however, these are partially restored to near wild-type levels when hrpA is subsequently
deleted.

Poly-proline translation is compromised in sick Δefp cells and in healthier fast-growing
suppressor mutants
The recovery of mutations that inactivate HrpA in fast-growing suppressor mutants
in Δefp cells suggests that either HrpA is involved in poly-proline translation and this is
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somehow restored in the absence of HrpA, or that HrpA is getting in the way of a critical
cellular process when cells are lacking EF-P. To test whether poly-proline translation is
improved in cells lacking both efp and hrpA, a reporter was designed containing a
polyproline motif that is an EF-P substrate with flanking residues reported to confer
stronger pausing in the absence of EF-P, KPPPW [17]. A control version of the reporter
contained residues in place of the poly-proline stall known not to participate in ribosomal
stalling, LASTL. Genes encoding firefly luciferase and nano luciferase were cloned
upstream and downstream of the test site, respectively, reporting on overall translation and
the efficiency of translation through the test motif. Additionally, trypsin cut sites were
inserted on either side of the test motif for subsequent mass spectrometry analysis of the
peptides synthesized during over-expression of the reporter. Figure 2-6 is a schematic
representation of both the poly-proline and control reporters with indicated epitopes for
Western blotting and expected masses. Several observations were made from overexpression and western blot analysis in regards to the translation of the reporter (Figure 27). In all strains (parent, ΔhrpA, Δefp, and Δefp ΔhrpA) the full-length control reporter is
synthesized, indicated by the presence of a band at approximately 82 kDa. In the case of
the poly-proline version of the reporter, bands at both 82 kDa and 65kDa reveal that cells
with EF-P have a difficult time translating through the test motif, however, the abundance
of full-length reporter is substantially greater than that of a truncated species. Cells lacking
EF-P exhibit a severe deficiency in the ability to translate through the test site of polyproline reporter, evident by a more abundant band at 65 kDa. α-HIS and α-FLAG westerns
both show full-length reporter expression, but only the α-HIS western is able to show
truncated species. Inefficient translation of the poly-proline version of the reporter is
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present in both Δefp and Δefp ΔhrpA strains, confirming that although deletion of hrpA
improves the health of Δefp cells, translation of poly-proline motifs is still compromised.
Analysis of enzymatic activity of the over-expressed reporters corroborates the
findings from the Western blot analysis (Figure 2-8). Overall activity of both firefly (Figure
2-8A) and nano luciferase (Figure 2-8B) are shown, as well as the ratio of nano luciferase
output to firefly luciferase output (Figure 2-8C,D), indicating the efficiency of translation
through the test motif. Activities of firefly luciferase and nano luciferase are consistent
with both reporters in the parent and ΔhrpA strains and the ratio of enzyme activities in
these strains indicates no substantial change. Additionally, the ratio of the reported
activities for these enzymes demonstrates that the loss of HrpA has no influence on the
translation of either the control or poly-proline versions of the reporter. In Δefp cells,
expression of firefly luciferase from both the control and poly-proline versions of the
reporter is substantially increased from that of the parent; however, nano luciferase
expression from the poly-proline reporter is approximately a fourth of the level of nano
expression of the control in Δefp cells, and roughly half that of both reporters in the parent
strain, owing to impaired translation through poly-proline motifs. In healthier Δefp ΔhrpA
cells, firefly luciferase expression of the control reporter is restored to levels comparable
to the parent strain, yet increased in the poly-proline version of the reporter. Expression of
nano luciferase in Δefp ΔhrpA cells indicates impaired translation through poly-proline
motifs, however, the relative ratio of nano/firefly expression from the poly-proline reporter
is similar to that of the parent strain.
The over-expressed reporters were purified in denaturing conditions, digested with
trypsin protease to isolate the test motif region, and peptides re-purified. The purified
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peptides were desalted and concentrated, and analyzed via MALDI-TOF mass
spectrometry (Figure 2-9). Mass peaks were identified in all strains corresponding to fulllength reporter peptides in both the control and poly-proline versions. The only truncated
masses identified were present in Δefp and Δefp ΔhrpA cells and were consistent with
pausing at the third proline of the motif.
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Figures

Figure 2-1: Δefp fast-growing suppressor mutant spontaneous formation
LB agar petri plate showing sick Δefp colonies and fast-growing suppressor mutants
following incubation overnight at 37C.
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Figure 2-2: Δefp fast-growing suppressor mutant genomic DNA
Cultures of efp::kan were grown at 37C and passaged every 12 hours with plating on LB
agar plates in between each culture. Fast-growing suppressor mutants were identified and
restreaked for isolation. Resetreaked fast-growing efp::kan suppressor mutants were used
to purify genomic DNA for Illumina sequencing. Ethidium bromide agarose gel
electrophoresis demonstrates purified genomic DNA quality.
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Figure 2-3: Schematic representation of genomic mutations in isolated Δefp fastgrower suppressors
Analysis of genome sequencing data revealed mutations in hrpA. (A) The location of a
nonsense mutation is indicated with an asterisk and the location of an insertion element is
marked with IS1B. The isolated mutants had effectively inactivated the second half of
HrpA containing the S1-like domain of unknown function, DUF3418. (B) Large genomic
regions, approximately ~100kb in length, containing the hrpA orf were deleted in an
independent experiment for isolation fast-growing suppressor mutants.
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Figure 2-4: Deletion of hrpA improves the fitness of sick Δefp cells
Growth analysis of parent, ΔhrpA, Δefp, and Δefp ΔhrpA strains on solid media and in liquid
culture. (A) Petri plate comparison of the growth phenotypes of parent, Δefp, ΔhrpA, and
Δefp ΔhrpA strains. The deletion of hrpA partially restored the growth of Δefp cells, but
has no influence on the growth of the efp+ parental strain. (B) Growth of parent, Δefp,
ΔhrpA, and Δefp ΔhrpA strains in liquid culture. The growth rates of each strain are
consistent with deletion of hrpA partially restoring the growth of Δefp cells.
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Figure 2-5: Ribosome production and polysome formation in Δefp and Δefp ΔhrpA
cells
Parent, ΔhrpA, Δefp, and Δefp ΔhrpA polysome gradient profiles. Deletion of hrpA alone
confers not apparent phenotype. The absence of efp results in compromised subunit
maturation, monosome production, and polysome formation compared to the parent strain.
Removal of hrpA from Δefp cells restores relative subunit to monosome ratios indicating
improved subunit maturation and monosome production, and partially restored polysome
formation.
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Figure 2-6: Schematic representation of the dual luciferase poly-proline reporter.
Architecture of the dual luciferase poly-proline reporter to test translation of poly-prolines.
A poly-proline and control test site, indicated by a triangle, are flanked by an upstream
Firefly luciferase and a downstream Nano luciferase. The Firefly luciferase reports on
overall translation of the reporter. Nano luciferase readout reports translation through test
site. The ratio of Nano luciferase output to Firefly luciferase output gives the ratio of
ribosomes able to translate the through the test motif to those that began translation,
indicating translation efficiency.
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Figure 2-7: Cells lacking EF-P produce truncated dual luciferase reporter.
Expression of control and poly-proline versions of the dual luciferase reporter. Cell lysates were subjected to SDS-PAGE and either
stained with coomassie (A) or transferred to PVDF membrane for western blotting. (B) α-HIS probing of expressed reporter
demonstrates full-length reporter expression in all strains, however, in cells lacking EF-P, the majority of the reporter expressed is
a truncated form, even in healthier Δefp ΔhrpA cells. (C) α-FLAG probing of expressed reporter protein detects only full-length
protein. Cells lacking EF-P produce substantially less full-length poly-proline reporter compared to Δefp cells expressing the control
reporter or cells with EF-P expressing either version of the reporter.
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Figure 2-8: Translation of full-length reporter is impaired in cells lacking EF-P
Activities of Firefly luciferase (A) and NanoLuc luciferase (B) were measured from cells
expression either the control or poly-proline version of the dual luciferase reporter. (A) The
output of Firefly luciferase reports on the overall translation of the reporter. (B) NanoLuc
luciferase activity reports on translation through the test motif, producing full-length
reporter protein. (C) The outputs of Firefly and NanoLuc were used to calculate a ratio of
NanoLuc/Firefly luminescence, representing the efficiency of translation through the test
motif.
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Figure 2-9: Δefp cells produce truncated poly-proline test motif
Control and poly-proline versions of the dual luciferase reporter were purified and trypsin digested. Masses corresponding to fulllength control (green arrows) and poly-proline (blue arrows) peptides were detected in parent, ΔhrpA, Δefp, and Δefp ΔhrpA strains.
Truncated peptides (red arrows) were only detected in strains lacking EF-P.
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Discussion

Fast-growing Δefp suppressor mutants were isolated and their genomes sequenced,
revealing mutations in an uncharacterized RNA helicase caleld HrpA. Each of the
discovered mutations effectively inactivated the second half of hrpA and conferred a
healthier phenotype compared to a sick Δefp strain. A ΔhrpA allele was transduced into
Δefp cells and the recovered transductants had improved fitness, indicating that inactivation
of hrpA alone was sufficient to improve the health of Δefp cells. Physiological defects that
arise from the absence of EF-P – ribosomal subunit maturation and decreased polysome
formation – were evaluated using polysome profiling. Deletion of hrpA did not display
ribosomal subunit or polysome defects, consistent with solid and liquid media growth
observations. When hrpA was deleted from Δefp cells, ribosomal subunit defects were
ameliorated, and monosome and polysome formation was restored to near wild-type levels.
Because EF-P aids ribosomes in the translation of poly-proline motifs, it was
hypothesized that HrpA participates in poly-proline translation and this somehow becomes
restored in the absence of HrpA, reducing the dependence on EF-P. This hypothesis was
tested using a dual luciferase reporter measuring the efficiency of poly-proline translation.
Using a combination of western blot analysis, reporter enzymatic activity, and mass
spectrometry, translation efficiency was evaluated in parent, ΔhrpA, Δefp, Δefp ΔhrpA
strains. Analysis of the data revealed that faster-growing Δefp ΔhrpA cells still experience
defects in translation of poly-proline motifs. Masses consistent with full-length peptides
for both the control and poly-proline version of the reporter were present in all strains. The
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presence of full-length peptides stemming from translation of the poly-proline version of
the reporter indicates that despite poly-proline translation impairment in Δefp cells,
ribosomes exhibit transient pausing at poly-prolines rather than hard stalling as with nonstop mRNAs, eventually overcoming the slow kinetics of transpeptidation involving
consecutive proline residues. This observation possibly explains why ribosome rescue
systems, such as trans-translation, have not been demonstrated in the context of polyproline mediated ribosome pausing [20]. Furthermore, pausing at poly-proline motifs may
not be all that deleterious to cells as previously thought and may provide a regulatory
mechanism for expression, folding, or transmembrane helix insertion [64]. Interestingly,
even in strains where EF-P is present, translating the poly-proline test motif was still
problematic. This illustrates that translation of consecutive prolines is problematic for
ribosomes.
The ultimate take away from the results of the dual luciferase poly-proline reporter
is that despite improved fitness of Δefp ΔhrpA cells, their ability to synthesize poly-prolines
has not improved compared to sick Δefp cells, however, these cells produce more fulllength reporter. This does not nullify the implication that HrpA is involved in poly-proline
translation, but it does demonstrate that the loss of HrpA in Δefp cells does not relieve the
dependence on EF-P. There are some potential explanations for HrpA exacerbation of Δefp
sickness. For example, if ribosome pausing at poly-proline motifs is a regulatory
mechanism, HrpA may be involved in carrying out downstream steps following pausing,
and the loss of EF-P results in a hyperactive HrpA. Moreover, HrpA may in fact be an
uncharacterized ribosome rescue system that acts on ribosomes stalled on intact mRNAs
whose function becomes deleterious to cellular physiology when EF-P is absent. A
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ribosome rescue system for ribosomes stalled on intact mRNAs has been previously
proposed, but a clear mechanism and classification of proteins involved has yet to be
demonstrated [20, 65, 66]. An explanation for more full-length reporter being produced in
Δefp ΔhrpA cells is that ribosomes are pausing at the polyproline motif, however, the
absence of HrpA is allowing ribosomes more time to translate through the pause.
Another compelling observation is that the majority of the sickness in Δefp cells is
a result of the presence of HrpA and that problematic translation of poly-proline motifs is
not as detrimental as previously thought. The attenuated sickness in Δefp ΔhrpA cells is
similar to the phenotype of Bacillus subtilus efp mutants that do not display a sickness
phenotype, but rather exhibits swarming motility deficiency. B. subtilis does not encode an
HrpA homolog. This is an important experimental observation that should be accounted
for in future studies of cells lacking EF-P.
Further analysis of the mass spectrometry data of the dual luciferase reporter may
provide beneficial information. For instance, in cells lacking EF-P, masses corresponding
to full-length and truncated peptides were detected but an assessment of the fidelity of
incorporated residues may reveal an underlying mechanism for HrpA. Moreover,
production of NanoLuc in Δefp ΔhrpA cells being greater than that of any other strain tested
warrants further investigation.
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CHAPTER 3: MUTATIONAL ANALYSIS OF HRPA FUNCTION

Preface

This chapter was composed entirely by R.J.W. Comments from S.D.M. were incorporated
into the final version presented here.

Introduction

Classification and assignment of known RNA helicases relies primarily on
sequence and structural data, and much of the sequence-based classification is determined
upon a series of conserved motifs identified in known helicases [29]. An example of this
is in defining the difference between DEAD-box and DEAH-box RNA helicases, who both
reside within Super Family 2, and perform NTP hydrolysis much in the same manner.
While these two subfamilies differ in sequence in other regions, the main qualifier for their
distinction is in the sequence of their NTPase active site residues, D-E-A-D and D-E-A-H.
Despite the difference in their classification, these enzymes utilize the energy from NTP
hydrolysis to perform their function, using well-characterized Walker A and Walker B
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motifs. Because Walker A and Walker B motifs are present in many proteins that utilize
NTP hydrolysis for mechanical energy, residues critical for their function have been
established and the roles each residue plays in NTP hydrolysis characterized.
HrpA belongs to the DEAH subfamily of the Super Family 2 of RNA helicases and
has strong homology to many members of this protein class, including PRP2, 16, 22, and
43 from Saccharomyces cerevisiae. Biochemical characterization of these RNA helicases
from S. cerevisiae has demonstrated their involvement in precursor mRNA splicing and
mutational studies have elucidated the mechanism behind the roles that each play [45, 47].
The genetic and biochemical relationship between EF-P and HrpA presented earlier
demonstrates a unique opportunity to identify residues critical for HrpA’s function by
evaluating their ability to restore Δefp sickness and to assess their influence on cells when
EF-P is present.
The helicase core region of RNA helicases contains motifs responsible for NTP
hydrolysis and those functioning in substrate binding and helicase functions. Outside of
the helicase core are N- and C-terminal extensions that dictate the behavior of RNA
helicases, including substrate specificity or co-factor recruitment [29, 38]. The majority of
the sequence of HrpA contains strong homology to other closely related RNA helicases,
however, the large S1-like C-domain of HrpA is not found with strong sequence similarity
in other taxa and has been dubbed DUF3418, or domain of unknown function. This region
was inactivated in each of the recovered and sequenced fast-growing Δefp suppressor
mutants. Investigations of the C-domain of HrpA have the potential to yield beneficial
observations indicating substrate specificity, moving closer to a biological role for HrpA.
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Materials & Methods

Bacterial strains and plasmids
Strain SM1344 (BW30270, an fnr+, rph+ derivative of MG1655, with the rna open
reading frame [ORF] replaced by FLP recombination target [FRT] site) was used as wildtype (WT) E. coli for this study. The genes encoding hrpA and efp were deleted by
recominbeering in strain SM1036 (DY378, W3110 λcI857 Δ[cro-bioA]) using selection for
a FRT-flank kanamycin resistance gene with 25 μg/ml kanamycin [58]. Mutants of hrpA
and efp were P1 transduced into 1344 and the modifications verified by diagnostic PCR
and DNA sequencing [59, 60]. Removal of the kanamycin resistance gene at both hrpA
and efp loci was performed using site specific recombination with plasmid pCP20. pCP20
is a plasmid carrying both ampicillin and chloramphenicol resistance genes, exhibits
temperature sensitive replication, and expresses a yeast FLP recombinase required for site
specific recombination [61]. Kan resistant deletion mutants were transformed with pCP20
and ampicillin resistant transformants were selected at 30C with 150 μg/ml ampicillin.
Four transformants of each deletion were restreaked on non-selective LB plates for
isolation and incubated at 37C to suppress pCP20 replication. Colonies were then streaked
to test for loss of resistance towards ampicillin and kanamycin.
For complementation, wild-type hrpA was PCR amplified from genomic DNA of
SM1344 using Q5 polymerase (New England Biolabs) and ligated into a derivative of the
pTrc99a plasmid [62]. Alanine substitutions at residues within hrpA were performed using
‘Round the horn site-directed mutagenesis and transformed into ΔhrpA and Δefp ΔhrpA
strains.
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Growth media and conditions
In general, all strains were grown in LB broth or on LB plates supplemented with
0.2% glycerol, 0.2% glucose, and appropriate antibiotic where needed.

Preparation of polysomes
In general, overnight cultures of desired strains were grown in LB with 0.2%
glycerol, 0.2% glucose, with antibiotic selection if needed, at 30C. Overnight cultures
were diluted 1/100 in LB with 0.2% glycerol, 0.2% glucose, and 10 mM sodium
bicarbonate and grown at 37C with shaking until cultures reached early exponential phase,
approximately 2 hours. At time of harvest, cultures were rapidly chilled by being poured
over buffered crushed ice pulled from a -80C freezer just at the time of harvest, and
immediately placed on ice. Cells were collected by centrifugation at 12,000 x g for 2
minutes, washed with cell wash buffer (25 mM K +-HEPES, 150 mM sodium chloride, 20
mM magnesium acetate, pH 7.5). After washing, cells were pelleted by centrifugation at
12,000 x g for 2 minutes and resuspended in 750 μls HT-20 (25 mM HEPES-Tris, 100 mM
K+-glutamate, 20 mM magnesium acetate, 14 mM β-mercaptoethanol, 0.05% Tween-20,
pH 7.5). For lysis, 100 μls of 0.1 mm zirconia disruption beads were added to resuspended
cells and lysis performed using an MP Biomdicals FastPrep-24 5G homogenizer at 10.0
m/sec for 30 seconds. Lysates were clarified 2X by centrifugation at 18,000 x g for 15
minutes at 4C and lysates transferred to fresh 1.7 ml microfuge tubes. Lysates were
normalized by measuring the absorbance at 260 nm of a 1/100 dilution in 10 mM Bis-Tris
pH 6.5.
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Ultracentrifugation and polysome profiles
200 μl aliquots of cell lysates were layered onto 10-40% sucrose gradients prepared
with supplemented HT-20 using a gradient master (Biocomp) and centrifuged in an SW41 rotor at 35,000 rpm (151,000 x g) for 3.5 hours at 4C. Polysome profiles were generated
during fractionation with a gradient fractionator (Biocomp).

Western blotting
1 ml fractions from polysome gradients were collected. 5 μls of 10 mg/ml linear
polyacrylamide (LPA) was mixed with 500 μls of each fraction and samples were
precipitated by mixing with 1 ml ice cold 95% ethanol and storing at -20C overnight. Next
day, samples were centrifuged at 18,000 x g for 30 minutes at 4C, supernatant discarded
and pellets washed with 500 μls of 75% ethanol. Pellets were then centrifuged at 18,000 x
g for 1 minute and pellets dried with 200 μls of 95% ethanol, followed by centrifugation at
18,000 x g for 1 minute. The supernatant was discarded and pellets dried using a speedvac
(Thermo Fisher). 5 μls of 100 mM Tris-Cl 8 M urea pH 8.5 was added to each pellet. Once
pellets were dissolved, 20 μls of SDS-PAGE sample buffer (100 mM Tris-Cl pH 8.5, 50
mM β-mercaptoethanol, 7% SDS, 0.1% bromophenol blue, 40% glycerol) and boiled for
5 mins at 100C. Samples were loaded on a 10 well, 12% acrylamide bis-Tris protein gel
and run in 1X MOPS running buffer (Boston Bioproducts) at 30 mA/gel for 90 minutes.
Following electrophoresis, gels were either stained with coomassie blue or transferred to
PVDF membranes (Idea Scientific) and blocked with 10% gelatin from cold water fish skin
(Sigma) in blocking buffer (20 mM K+-HEPES, 150 mM NaCl, 0.05% Tween-20, 0.2 mM
EDTA, pH 7.5). Monoclonal mouse-anti-polyHistidine-Peroxidase (Sigma) (1:10,000)
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was used to probe for products from expression of the dual luciferase reporter. Membranes
were washed 3X prior to imaging using a FlourChem E imager (Protein Simple).

MNase treatment of polysome lysates
Growth of cultures, preparation of polysomes, ultracentrifugation, and fractionation
was performed as previously described. For MNase treatment, lysates were diluted to an
A260 of 50 and aliquoted. 10U/A260 of MNase was added to each lysate and samples were
incubated at 37C for 15, 30, 45, or 60 minutes and MNase activity quenched by addition
of 6 mM egtazic acid (EGTA) to chelate calcium ions required for MNase activity.

Results

ATPase activity is required for HrpA function and restoration of Δefp sickness
HrpA is a member of the Super Family 2 of RNA helicases and further classified
into the DEAH/RHA subfamily. RNA helicases are classified based on sequence and
structural data, and several of the classical motifs have been well-characterized.
Exacerbation of Δefp sickness by HrpA permits mutational analysis to determine residues
critical for HrpA’s function. Alanine substitutions were performed with ‘Round-the-horn
site directed mutagenesis of plasmid borne wild-type HrpA and expressed in-trans in
healthier Δefp ΔhrpA cells. Schematic representation of mutations and their locations
within HrpA are shown in Figure 3-1.
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Complementation of wild-type HrpA is sufficient to restore the sickness of Δefp
cells. Furthermore, Δefp ΔhrpA cells complemented with wild-type HrpA appear to be more
sick than Δefp cells with endogenously expressed wild-type HrpA. This is an indication
that the exacerbation of sickness in Δefp cells caused by HrpA is dose dependent. Mutations
at several residues within motifs I, II, and III were unable to restore the sickness of Δefp
cells when compared to wild-type HrpA (Figure3-2) and, therefore, are critical for HrpA’s
function.

HrpA mutants cause dysfunctional ribosome maturation and polysome formation
Using the library of engineered HrpA mutants, sucrose density polysome gradients
were used to evaluate their influence on cellular physiology when expressed in-trans in
ΔhrpA cells (Figure 3-4). Mutations within motifs I and II of HrpA exhibited defects in
ribosome production indicated by an increase in 30S and 50S subunit peaks, and a
substantial decrease in monosome and polysome formation.

HrpA comigrates with polysomes in sucrose density gradients
RNA helicases are involved in all aspects of RNA metabolism. To help discern
HrpA’s involvement in cellular physiology in Escerichia coli, wild-type HrpA, expressed
in-trans, was tracked via western blotting in sucrose density polysome gradients. Western
blotting of polysome gradient fractions revealed that wild-type HrpA co-migrates with
polysomes.
In addition to the observation that wild-type HrpA co-migrates with polysomes, a
mutant version of HrpA was generated where only the C-domain was present, and the
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ATPase and helicase motifs present in the N-domain were replaced with the fluorescent
protein mClover3. During previous efforts to express a C-domain truncation alone it was
observed that either the C-domain by itself is unstable or is not retained in the soluble
fraction of cell lysates. Fusing the C-domain to mClover3 improved detection using
Western blotting. The fusion protein was expressed in ΔhrpA cells in-trans and tracked
using Western blot. The sequence of the C-domain of HrpA present specifically correlates
to the domain of unknown function 3418 (DUF3418). Western blotting revealed that the
C-domain of HrpA is responsible for co-migration with polysomes.

HrpA is associated with actively translating ribosomes
Figure 3-5 demonstrates that wild-type HrpA co-migrates with polysomes in
sucrose density gradients. Unfortunately, other cellular components migrate through
gradients similarly to polysomes for the very same reason despite not being associated with
translation; they are large macromolecular complexes. To discern if HrpA is associated
with actively translating ribosomes or another large complex within the cell, lysates were
treated with micrococcal nuclease (MNase) and incubated at 37C for 15, 30, and 45
minutes prior to ultracentrifugation. Western blotting of gradient fractions revealed that as
polysomes are depleted and resect to fractions containing monosomes, HrpA migration is
reserved to the early fractions. This indicates that HrpA is associated with actively
translating ribosomes. Moreover, the remaining Western blot signal still present in
polysomal fractions after prolonged MNase treatment (45 minutes) may suggest that HrpA
is associated with more stable, or MNase resistant, polysomes. In support of this
observation is the remaining disome and trisome, two and three ribosomes respectively,
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remaining even after forty-five minutes of MNase treatment where HrpA remains in an
abundance greater than the nearby fractions.
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Figures

Figure 3-1: HrpA mutants
Schematic representation of engineered HrpA mutants. (A) Full-length versions of HrpA
generated with point mutations at highly conserved residues that are critical for function in
other related DEAH-box RNA helicases. Residues mutated are indicated by a •. (B) An Ndomain variant of HrpA containing only the sequence up until the beginning of the domain
of unknown function, DUF3418. (C) The C-domain of HrpA containing the DUF3418
fused to mClover3.
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Table 3-1: Engineered HrpA mutants and residue function
Wild-type

Substituted

residue

residue

K106

Restore Δefp

Motif

Role

alanine

I

coordinate β-phosphate

no

this study

T107

alanine

I

coordinate Mg++

no

this study

D197

alanine

II

coordinate Mg++

no

this study

E198

alanine

II

coordinate H2O

no

this study

R399

alanine

II

stabilize transition state

no

this study

S229

alanine

III

links atp hydrolysis to activity

partial

this study

T231

alanine

III

links atp hydrolysis to activity

partial

this study

N-domain

truncation

n/a

atpase/helicase

no

this study

C-domain

truncation

n/a

unknown (DUF3418)

no

this study
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sickness

Where used

Figure 3-2: HrpA mutant complementation in Δefp ΔhrpA cells
Petri plate comparing the growth phenotypes of HrpA mutants complemented into Δefp
ΔhrpA strains. Mutations in HrpA within the DEAH-box responsible for ATP hydrolysis
are unable to restore Δefp sickness. Expression of the N-domain and the C-domain
independently of each other is not sufficient to restore Δefp sickness.
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Figure 3-3: Deletion of hrpA displays no phenotype
Polysome profiles of parent, ΔhrpA, and a ΔhrpA strain complemented with wild-type
HrpA. Polysome profiles reveal that there is no apparent phenotype from the deletion of
hrpA and that complementation of wild-type HrpA results in a profile similar to that of the
parent strain.
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Figure 3-4: Influence of HrpA mutants on ribosome production and polysome
formation
Polysome gradient comparison of HrpA mutants expressed in trans in ΔhrpA cells
demonstrating their deleterious influence on ribosome subunit maturation and polysome
formation. (A) Mutations at residues in motif II responsible for coordination of NTP
hydrolysis. (B) Mutations at residues in motif III linking the energy from NTP hydrolysis
to mechanical function. (C) N-domain only and C-domain only truncated versions of HrpA.
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Figure 3-5: HrpA co-migration with polysomes
Polysome gradient and western blot of fractions from wild-type HrpA (A) and HrpA Cdomain fused to mClover3 fluorescent protein (B). Wild-type HrpA co-migrates with
polysomes in sucrose density gradients (A). The C-domain of HrpA, also assigned as a
domain of unknown function 3418 (DUF3418) is responsible for HrpA’s co-migration with
polysomes.

50

Figure 3-6: HrpA is associated with actively translating ribosomes.
Control and MNase treated polysome gradients with western blot tracking of wild-type
HrpA association of polysomes.
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Discussion

Mutational analysis of HrpA using alanine substitutions at several highly conserved
residues in other closely related RNA helicases was performed to identify those residues
critical for HrpA’s function and to begin to understand its role in cellular physiology. The
discovery that wild-type HrpA exacerbates Δefp sickness in E. coli provides a genetic
system to test the functionality of engineered mutants simply screening for restored Δefp
sickness when HrpA mutants are introduced in-trans. This is supported by the fact that
Δefp sickness can be restored by reintroducing a plasmid-borne wild-type HrpA.
While each of the mutants shown in Figure 3-2 were unable to restore Δefp sickness
to the same degree as wild-type HrpA, each mutant had a varied impact on how much
sickness was restored, with mutations within the same motif displaying similar effects. Of
the mutants tested, mutations within motif II appeared to be the most detrimental to HrpA
function, followed by motif I, and finally motif III. Within motif II resides residues that are
responsible for NTP hydrolysis. While motif I also contains residues that participate in
NTP hydrolysis, these residues participate more in binding the ribose sugar and nitrogen
base, and stabilizing the β-phosphate of the triphosphate molecule, whereas the residues in
motif II are directly responsible for hydrolysis of the γ-phosphate. This is possibly an
indication that the identity of the NTP used for hydrolysis is not necessarily important and
that any instability of the β-phosphate can eventually be overcome kinetically.
Mutations within motif III, home to what has been termed the communication
domain, linking the energy from NTP hydrolysis to mechanical activity, appear to not have
as substantial impact on HrpA’s function as the earlier mentioned mutations. Δefp sickness
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in S229A and T231A HrpA mutants was largely restored, demonstrating that while not as
active as wild-type, the enzyme may be partially active despite a dysfunctional motif III so
long as NTPase activity is present. N-domain and C-domain truncations of wild-type HrpA
had no impact when expressed in Δefp ΔhrpA cells indicating that full-length wild-type
HrpA is required for the enzyme to function.
While some HrpA mutants were unable to restore Δefp sickness, they did impart
some influence on cellular physiology as evident by Figure 3-2. This could be explained
by the mutant versions of the enzymes being partially active, or that they themselves, are
deleterious to cells. Given the relationship between HrpA and EF-P, and the level of
involvement EF-P has in translation, HrpA participation in translation was not out of the
question. Using the parent, ΔhrpA, and a strain with HrpA complemented via a plasmid, it
was demonstrated that deletion of hrpA and reintroduction on a plasmid imparts not
physiological influence on cells (Figure 3-3). Polysome gradients of cells complemented
with a mutant version of HrpA were generated to determine their impact on translation
(Figure 3-4). Substantial defects in subunit maturation, monosome production, and
polysome formation were observed in all mutants tested. No impact was observed with Nand C-domain truncation mutants, consistent with observations from complementation
experiment in Figure 3-2. Such an impact on the translation machinery suggests that mutant
versions of HrpA are getting in the way of some critical process, however, this observation
does not directly implicate HrpA in association with ribosomes.
The ability of the mutant versions of HrpA to have such an impact on ribosomal
subunits and polysomes indicates a strong relationship between HrpA and translation.
Furthermore, an influence on polysomes suggests that HrpA may interact with individual
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ribosomes. To determine if HrpA is in fact associated with polysomes, fractions from
polysome gradients were used for western blotting to track HrpA. It was determined that
HrpA is present throughout the entirety of the gradient and co-migrates with polysomes,
however, this does not necessarily demonstrate that HrpA is associated with actively
translating ribosomes. Ribosomes, and polysomes which contain multiple ribosomes,
travel in sucrose density gradients because of their shape and size. While ribosomes are
large macromolecular machines, there exists other cellular components with the disposition
to migrate similarly to ribosomes and polysomes. Further investigation to ascertain cellular
components of which HrpA is associated was warranted.
To probe for what HrpA associates with, lysates were treated with MNase in a
manner similar to protocols for ribosome profiling experiments. MNase is a universal
nuclease, targeting DNA and RNA with preference for single stranded RNA, and is used
in ribosome profiling experiments to generate ribosome protected fragments of RNA for
downstream sequencing. Treatment with MNase degrades RNA between ribosomes in a
polysome, converting polysomes into monosomes, shifting their migration from later
fractions in gradients, to those fractions containing single ribosomes, or monosomes.
Treatment was performed to evaluate the behavior of HrpA’s association as polysomes are
depleted. Analysis of western blots from untreated, 15 min., 30 min., and 45 min.
treatments shows that as polysomes are converted to monosomes, HrpA’s migration
switches from later fractions where polysomes were previously present to early fractions.
This observation alone suggests that HrpA is associated with actively translating
ribosomes. In support of this is the fact that the remaining disome and trisome (two and
three ribosomes, respectively) peaks remaining even after 45 minutes of MNase treatment
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show an increased abundance when compared the large amount of monosomes present in
adjacent fractions. The remaining disome and trisome peaks of the polysome fractions may
possibly contain ribosomes that are resistant to MNase treatment, sterically blocking access
to the RNA between these ribosomes. Moreover, the results of this experiment demonstrate
HrpA’s association with actively translating ribosomes; however, it is still unknown if
ribosomes themselves are the target of HrpA’s activity. It is possible that HrpA’s molecular
function is performed on mRNA’s that are being actively translated, and HrpA’s migration
through polysome gradients shifts as these mRNAs are degraded during the MNase
treatment.

55

CHAPTER 4: OVER-EXPRESSION, PURIFICATION, AND INVITRO BIOCHEMICAL CHARACTERIZATION

Preface

This chapter was composed entirely by R.J.W. Comments from S.D.M. were incorporated
into the final version presented here.

Introduction

HrpA is an RNA helicase belonging to the Super Family 2, DEAH subfamily of
helicases, and much of this classification is owed to sequence alignment data, as is the case
with the majority of other RNA helicases [29]. Despite the wealth of sequence and
structural data that is used for classification of RNA helicases, much of this information is
not useful to determining a helicase’s role in cellular physiology. N- and C-terminal
extensions outside of the conserved helicase core are not that highly conserved amongst
helicase family members and, in most cases, these extensions dictate substrate specificity,
either directly or indirectly [36]. While most RNA helicases have not demonstrated much
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substrate specificity when tested in vitro and, of the crystal structures that exist with RNA
helicase-substrate interactions, there is no apparent involvement of specific nucleotide
recognition, there is still much to gain from purification and in vitro characterization of an
enzyme.

Materials & Methods

Protein overexpression and purification
HrpA wild-type and mutants were purified using a C-terminal FLAG-His6 tag after
being overexpressed from clones in a pTrc99a variant at 37C in DH5α. Induction was
performed with 0.5 mM IPTG for 3 hours. Following induction, cells were harvested by
centrifugation at 12,000 x g for 4 minutes in a Sorvall RC6+ centrifuge, cell pellets washed
with 1/10th culture volume of cell wash buffer (25 mM K +-HEPES, 150 mM sodium
chloride, 20 mM magnesium acetate, pH 7.5). After washing, cells were pelleted by
centrifugation at 12,000 x g for 3 minutes and resuspended in lysis buffer (25 mM HEPESTris, 100 mM K+-glutamate, 1 mM EDTA) supplemented with protease inhibitor cocktail
(Calbiochem) and stored at -80C. For lysis, cells were thawed at 4C and lysozyme added
to a final concentration of 0.5 mg/ml. Cells were lysed for ~30 minutes at 4C with rocking.
After lysis was apparent by increased viscosity, an equal volume of 2X nickel binding
buffer (25 mM HEPES-Tris, 100 mM K+-glutamate, 500 mM NaCl, 10.5 mM MgOAc, 0.5
mM CaCl2, 14 mM β-mercaptoethanol, 2 mM imidazole, 0.05% octyl glucose neopentyl
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glycol, 10% glycerol) supplemented with Pierce Universal Nuclease (25 U/ml) (Thermo
Fisher).
Once viscosity was reduced, the lysate was cleared by centrifugation at 20,000 x g
for 10 minutes at 4C, the soluble fraction diluted two-fold, and mixed with two mls of
nickel-NTA slurry (Thermo Fisher) pre-washed in a 1X nickel binding buffer. Following
2-hour binding at 4C, the nickel resin was washed 3X with 1 ml of nickel binding buffer
supplemented with 15 mM imidazole and the protein eluted 3X with 1 ml nickel binding
buffer supplemented with 350 mM imidazole. The 3 mls of eluate was diluted to 10 mls
with H2O and 1 ml of prewashed hydroxyapatite (HA) (Bio-Rad) slurry was added and
protein allowed to bind at 4C with rocking. Following binding, the resin was transferred
to a gravity column, washed 3X with 500 μls of HA buffer (12.5 mM Tris-Cl, 50 mM NaCl,
14 mM β-mercaptoethanol, 10.5 mM MgOAc, 0.05% OGNG, 5% glycerol) supplemented
with 75 mM sodium phosphate, and protein eluted 3X with 500 μls of HA buffer
supplemented with 600 mM sodium phosphate. Before quantification and storage, purified
protein was buffer exchanged into storage buffer (25 mM HEPES-Tris, 100 mM K+glutamate, 500 mM NaCl, 10 mM MgOAc, 14 mM β-mercaptoethanol, 0.05% octyl
glucose neopentyl glycol).
Purification of wild-type elongation factor P was performed with similar methods
from purification of HrpA. Wash and elution buffers for purification of hydroxyapatite
resin bound EF-P contained 10 mM and 75 mM sodium phosphate, respectively.
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Total RNA purification
1 ml overnight cultures of parent, ΔhrpA, Δefp, Δefp ΔhrpA were grown in LB broth
supplemented with 0.2% glycerol and 0.2% glucose at 30C. Next day, cultures were
diluted 1/100 in 5 mls of LB broth supplemented with 0.2% glycerol, 0.2% glucose, and
10 mM sodium bicarbonate. Cultures were grown at 37C for 2 hours. At time of harvest,
1 ml of culture was added to 110 μls of ice cold RNA stop (10% phenol in ethanol) and
placed on ice. Cells were harvested by centrifugation at 8000 x g for 2 min and the
supernatant removed from the cell pellet. Cell pellets were resuspended in 200 μls of MGE
(10 mM K+-MOPS, 10 mM glucose, 2 mM EDTA, pH 7.2) and 100 μls of 0.1 mm zirconia
beads were added. Cells were lysed using an MP Biomdicals FastPrep-24 5G homogenizer
at 10.0 m/sec for 30 seconds. Following lysis, samples were briefly centrifuged to collect
material away from the cap and 500 μls of 5.5 M guanidine thiocyanate was added, samples
vortexed and lysates clarified by centrifugation at 18,000 x g for 10 minutes. Lysates were
transferred to fresh tubes and 1 μl of 50 mg/ml linear polyacrylamide was added. 400 μls
of acidic phenol (Fisher Sci.) and 200 μls of chloroform were added, and samples vortexed
to emulsion. Samples were then centrifuged for 1 min at 10,000 x g and the aqueous phase
transferred to fresh tubes. 200 μls of chloroform was added, samples vortexed, centrifuged
at 10,000 x g for 1 min, and the aqueous phase transferred to new tubes. 900 μls of 100%
isopropanol was added and samples precipitated overnight at -20C. Next day, samples
were centrifuged at 18,000 x g for 45 minutes at 4C to pellet precipitated material.
Supernatant was decanted and pellets washed with 500 μls of 75% ethanol and then dried
with 95% ethanol. Complete drying of pellets was performed using a …. Pellets were
dissolved in 10 mM Bis-Tris, 0.1 mM EDTA, pH 6.5. Total RNA purity and concentration
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was determine using a BioTek Synergy MX spectrophotometer. Total RNA quality was
assessed using 10 % urea-PAGE and staining with Sybr Green II dye (Invitrogen).

Genomic DNA purification
Freezer stocked parent strain was streaked onto an LB agar plate supplemented with
0.2% glycerol and 0.2% glucose. Colonies were then aseptically transferred from plates
and deposited into 1.7 ml microfuge tubes. 200 μls of resuspension buffer (50 mM Tris-Cl,
10 mM EDTA pH 8.0 with 50 μg/ml RNaseA) was added and cells vortexed into solution.
Approximately 100 μls of 0.1 mm zirconia disruption beads were added to resuspended
cells. Cells were then lysed 2X using an MP Biomdicals FastPrep-24 5G homogenizer at
10.0 m/sec for 1 minute. 500 μls of GuSCN buffer (5.5M guanidine thiocyanate, 0.1 M
sodium acetate pH 5.0) was added to lysed cells and insoluble cell debris pelleted for 5
minutes at 21,000 x g. The resulting supernatant was then transferred to a fresh 1.7 ml
microfuge tube, 100 μls of 100% isopropanol added, and tubes were vortexed to mix and
briefly spun down in a bench top mini-centrifuge to collect sample. Genomic DNA was
then bound to EconoSpin Silica Membrane Mini Spin columns, washed 3X with wash
buffer (5 mM K+-HEPES, 20 mM sodium chloride, 0.02 mM EDTA, 80% EtOH, pH 8.3)
and eluted 2X with 50 μls of elution buffer (5 mM Tris-Cl, 0.2 mM EDTA, pH 7.8). DNA
concentration and purity was measured using via spectrophotometer (BioTek) and DNA
quality evaluated by EtBr agarose gel electrophoresis.
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Polysome purification
Overnight cultures of Δefp and Δefp ΔhrpA strains were grown in LB with 0.2%
glycerol, 0.2% glucose, with antibiotic selection if needed, at 30C. Overnight cultures
were diluted 1/100 in LB with 0.2% glycerol, 0.2% glucose, and 10 mM sodium
bicarbonate and grown at 37C with shaking until cultures reached early exponential phase,
approximately 2 hours. At time of harvest, cultures were rapidly chilled by being poured
over buffered crushed ice pulled from a -80C freezer just at the time of harvest, and
immediately placed on ice. Cells were collected by centrifugation at 12,000 x g for 2
minutes, washed with cell wash buffer (25 mM K +-HEPES, 150 mM sodium chloride, 20
mM magnesium acetate, 500 mM ammonium chloride, pH 7.5). After washing, cells were
pelleted by centrifugation at 12,000 x g for 2 minutes and resuspended in polysome
purification buffer (25 mM HEPES-Tris, 100 mM K+-glutamate, 500 mM ammonium
chloride, 20 mM magnesium acetate, 14 mM β-mercaptoethanol, 0.05% Tween-20, pH
7.5). For lysis, 100 μls of 0.1 mm zirconia disruption beads were added to resuspended
cells and lysis performed using an MP Biomdicals FastPrep-24 5G homogenizer at 10.0
m/sec for 30 seconds. Lysates were clarified 2X by centrifugation at 18,000 x g for 15
minutes at 4C and lysates transferred to fresh 1.7 ml microfuge tubes. Entire lysates were
loaded onto 10-30% sucrose gradients prepared with polysome purification buffer and
centrifuged at 35,000 rpm for 8 hours in an SW-41 rotor (Beckman). The supernatant was
decanted and pelleted ribosomes resusupended in 500 μls polysome purification buffer.
Resuspended ribosomes were then loaded onto 10% sucrose cushions prepared with
polysome purification buffer. Samples were centrifuged at 35,000 rpm in an SW-41 rotor
for 3.4 hours. Pelleted ribosomes were resuspended in HT-20 and buffer exchanged into
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fresh HT-20 to remove residual ammonium chloride. Concentration of purified polysomes
was determined by absorbance at 260 nm. Quality of purified ribosomes was determined
by 10-40% sucrose gradient profiles. Activity of purified polysomes was assayed using
PURExpress in-vtiro protein synthesis kit (NEB) expressing a T7-dual luciferase construct.

Kinetic assays
HrpA’s ATPase activity was measured using a regenerative coupled assay [67]. A
20X assay mix (20 mM NADH, 150 mM phosphoenolpyruvate, and ~10 U/ml of pyruvate
kinase/lactate dehydrogenase mixture [Sigma]) was prepared in assay buffer (25 mM
HEPES-Tris, 100 mM K+-glutamate, 12 mM magnesium acetate, 0.05% octyl glucose
neopentyl glycol, 14 mM β-mercaptoethanol, pH 7.6), aliquoted, and frozen at -80C. 2X
assay mixes were prepared with assay buffer supplemented with the appropriate NTP and
potential substrate if needed. Thirty μls of this 2X assay mix was combined with thirty μls
of 2X enzyme. Fifty μls of the reaction mixture was transferred to a 96-well plate and the
loss of absorbance of NADH was measured at 340 nm in 1 minute intervals. Slopes of
straight lines fit to raw data were converted to NTPase rates using the extinction coefficient
for NADH at 340 nm, and rates of controls lacking enzyme subtracted. K m and Vmax values
were established at various concentrations of ATP or GTP by fitting to the MichaelisMenten equation using Prism 6 (GraphPad software).
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Results

HrpA can be overexpressed and natively purified
HrpA bearing a tandem affinity tag (HIS6-flag) was cloned into a derivative of the
pTrc-99a plasmid and overexpressed in DH5α. Overexpression and solubility was
confirmed via SDS-PAGE, indicating that HrpA can be overexpressed, tolerate an affinity
tag, and remains within the soluble fraction of cell lysates. Purification of wild-type HrpA
was performed using nickel affinity chromatography followed by hydroxyapatite
chromatography. The absorbance profile of purified HrpA was compared to that of what is
predicted in guanidine and observed to be absent of nucleotide absorbance, indicating that
the protein was purified without bound RNAs.

HrpA is a universal NTPase
Purified wild-type HrpA (Figure4-2A) was incubated with 1 mM ATP, GTP, CTP,
TTP, and UTP to determine its substrate specificity (Figure 4-2B). Incubation of purified
enzyme and NTPs was performed at 37C for 1 hour and the generated free inorganic
phosphate was measured using malachite green reagent. HrpA hydrolyzed each of the
tested NTPs with similar results, but did demonstrate a slight preference for CTP, indicated
by a greater presence of free inorganic phosphate.
The Km and V max values for HrpA were determined for both ATP and GTP (Figure
4-2C). For each NTP, the K m and V max values were relatively similar. For ATP, the
calculated Vmax was 28.26 μm min-1 with a K m of 15.59  1.3 μM. The calculated GTP
Vmax was 25.6 μm min-1 with a K m of 16.97  1.8 μM.
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HrpA is not stimulated by several tested factors
Several factors were used as potential substrates in stimulation of HrpA’s ATP
hydrolysis rate. Total RNA, genomic DNA, purified wild-type EF-P, and purified actively
translating ribosomes (Figures 4-3A-D) were tested with wild-type HrpA and incubated at
37C. There was no substantial difference observed between the substrates tested and the
HrpA only controls in terms of ATPase rates. Closely related DEAH-box RNA helicases,
including the HrpA homolog in B. burgdorferi, have been shown to exhibit at 10-fold
increase in ATPase activity in the presence of substrate, therefore, the slight increase in
activity in Figure 4-3A-D was determined not to be substantial.
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Figures

Figure 4-1: HrpA can be overexpressed and purified
Coomassie stained SDS-PAGE gels of wild-type HrpA overexpression and purification.
HrpA bearing a tandem affinity tag can be purified using nickel affinity chromatography
(A) and further purified using hydroxyapatite (B).
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Purified HrpA absorbance profile
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Figure 4-2: Purified HrpA absorbance profile
Plot of purified (blue) and the predicted (red) absorbance profile for HrpA in 6M guanidine.
The absorbance profile for purified HrpA is similar to that of the predicted absorbance
profile indicating no bound nucleotides were co-purified with the enzyme.
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Figure 4-3: Purified wild-type HrpA is a universal NTPase
Purified and buffer exchanged wild-type HrpA (A). (B) Purified HrpA was incubated with
1 mM ATP, GTP, CTP, TTP, and UTP for 1 hour at 37C and free inorganic phosphate
measured with malachite green. HrpA was able to hydrolyze all NTPs tested. (C) A
continuous-regenerative assay was used to measure HrpA hydrolysis rates at different
concentrations of ATP and GTP. Rates were fit to the Michealis-Menten equation to
calculate K m and Vmax.
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Figure 4-4: ATPase activity stimulation of wild-type HrpA
ATP hydrolysis stimulation of HrpA was tested with total RNA (A), genomic DNA (B),
purified wild-type EF-P (C), and purified ribosomes (D). In each case, none of the
substrates were able to substantially alter the ATP hydrolysis rate of wild-type HrpA.
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Discussion

Wild-type HrpA was successfully cloned, overexpressed, and purified, indicating
the prospects for downstream biochemical characterization. Testing the NTP preference of
HrpA revealed that all NTPs tested (ATP, GTP, CTP, TTP, and UTP) were hydrolyzed
with similar efficiency. A slight preference for CTP was observed, indicated by a higher
presence of inorganic phosphate following incubation. The observation of HrpA’s
universal NTP hydrolysis is consistent with other tested DEAH-box RNA helicases and
not a unique feature of HrpA alone. Other RNA helicases within the same subfamily of as
HrpA have also demonstrated ability to hydrolyze dNTPs [29]. The lack of substrate
specificity for DEAH-box RNA helicases has not been explained, and the mechanism for
its promiscuity remains ambiquous, but remains a curious feature of this class of RNA
helicases.
The hydrolysis rates for ATP and GTP, shown in Figure 4-2C, demonstrate further
that there is no clear specificity for a particular substrate. While other DEAH-box RNA
helicases have shown NTPase rate stimulation with the presence of RNA, and a few with
DNA, HrpA’s ATPase rate was relatively unaffected by any of the substrates tested. A
simple explanation for these observations is that HrpA’s specificity for its substrate is not
as promiscuous as is its NTP specificity. The large DUF3418 C-terminal domain has
potential to support this explanation given the observation that it is responsible for HrpA’s
co-migration with polysomes. Moreover, a quantitative analysis of E. coli’s proteome
revealed that HrpA is only present at an average of ~19 copies per cell in stationary phase,
yet HrpA imparts substantial deleterious effects on physiology when EF-P is absent [68].
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Further investigation using alternative potential substrates to stimulate the NTPase
rate of HrpA is warranted and may indicate an in vivo role. Classification of helicases based
solely on sequence and structural data has limitations, and several sequence-classified SF2
helicases have not demonstrated helicase activity. While E. coli’s HrpA has strong
homology to other DEAH-box RNA helicases, it’s in vivo role may not involve any
helicase activity.
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CHAPTER 5: CONCLUSIONS

Preface

This chapter was composed entirely by R.J.W. Comments from S.D.M. were incorporated
into the final version presented here.

Introduction

In Escherichia coli, the absence of elongation factor P (EF-P), a universally
conserved transpeptidation enhancer that facilitates poly-proline translation, induces a
sickness phenotype. Δefp cells to suffer from inefficient translation, ribosome subunit
maturation defects and decreased monosome and polysome formation. Much of this
sickness is owed to the presence of an uncharacterized ATP dependent DEAH-box RNA
helicase, HrpA, which is inactivated in fast-growing Δefp suppressor mutants. Cells lacking
EF-P grow notably slower than their wild-type parent strains, however, fast-growing Δefp
suppressor mutants were isolated and consistently found to have a disrupted hrpA open
reading frame. The absence of both EF-P and HrpA results in a healthier phenotype than
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Δefp cells alone, where ribosome subunit maturation defects and monosome and polysome
formation deficiencies are ameliorated, with restoration to near wild-type levels. Despite
the healthier phenotype, Δefp ΔhrpA cells still exhibit inefficient translation of proteins
containing poly-proline motifs.
Expression of wild-type HrpA in-trans revealed that the sickness caused by HrpA
in Δefp cells is dose dependent, with a higher level of HrpA present in cells correlating to
a stronger sickness phenotype. With the observation that much of the sickness upon initial
deletion of efp is contributed by the presence of HrpA, and previous reports indicating the
low protein copy number of HrpA in stationary phase E. coli, it is believed that HrpA must
be getting in the way of an essential cellular process when EF-P is absent [68]. HrpA was
observed to co-migrate with polysomes in sucrose density gradients and a C-domain only
version of HrpA, fused to a fluorescent protein, revealed that HrpA’s domain of unknown
function C-terminus is responsible for the co-migration. Nuclease treatment of lysates
revealed that as intact polysomes are depleted and converted to monosomes, the majority
HrpA’s migration pattern in sucrose density gradients resides within the first several
fractions, suggesting that not only does HrpA co-migrate with polysomes, it is associated
with actively translating ribosomes.
Several HrpA mutants were engineered to identify residues essential for HrpA’s
function and were found not to restore the sickness when expressed in-trans in Δefp ΔhrpA
cells. These same mutants, however, when expressed in ΔhrpA cells with wild-type EF-P,
resulted in detrimental effects on ribosome subunit maturation, monosome production, and
polysome formation.
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Polyproline translation is still impaired in healthier Δefp ΔhrpA strains
Initial explanations for HrpA’s exacerbation of Δefp sickness included that HrpA
was involved in translation of poly-proline motifs and the loss of HrpA reduced the
dependence on EF-P, improving the health of Δefp ΔhrpA cells. Using a dual luciferase
reporter containing a poly-proline test motif, translation efficiency in parent, ΔhrpA, Δefp,
and Δefp ΔhrpA cells was evaluated, and it was determined that despite the healthier growth
phenotype, poly-proline translation was still impaired (Figures 2-6 through 2-9). While
these results do not fully exonerate HrpA from involvement in poly-proline translation,
they do provide evidence that without EF-P, whether HrpA is present or not, cells still do
not make poly-proline motifs efficiently.

HrpA mutants have deleterious effects on ribosome subunit maturation and polysome
formation
Several HrpA mutants were engineered based on well-characterized motifs present
in other related RNA helicases. These mutants were used for complementation studies in
Δefp ΔhrpA cells and found not to be unable to restore the sickness Δefp cells, however,
their level of impact on cells was variable, suggesting that they were either partially active
or imposed some other influence on cells aside from the absence of EF-P. The mutants
were introduced in ΔhrpA and expressed in trans and found to cause substantial ribosome
subunit maturation, monosome production, and polysome formation defects. This
observation suggests that HrpA is involved in an essential cellular process and broken
versions of HrpA severely get in the way of this.
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Figures

Figure 5-1: HrpA bound RNAs can be purified
Tandem affinity tagged versions of RpoB (A) and HrpA (B) purified using nickel affinity
chromatography and M2 α-FLAG resing (Sigma) were used to extract bound RNAs (C).
RNA banding patterns between RpoB and HrpA were unique, indicating that bound species
were specific to the purified proteins. HrpA bound RNAs range in size from larger than
23S rRNA to approximately the size of tRNAs (50-70 nucleotides).
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Future Directions

Early efforts were focused on identifying and quantifying bound RNAs of purified
HrpA expressed at endogenous levels from its natural chromosomal locus. In pursuit of
this, a protocol was developed to gently purify large complexes and this was achieved with
great success, however, it was observed that RNAs ranging from a few thousand
nucleotides to those roughly the size of tRNAs (50-70 nucleotides) were bound to HrpA.
It is nearly impossible to discern RNAs bound due to specific interactions from those of
nonspecific interactions, therefore, other methods to elucidate HrpA’s physiological role
were employed. Several key goals were set in the initial phase of the project to provide a
foundation and establish numerous avenues of which to pursue to investigation HrpA’s
physiological role. The genetic relationship between EF-P and HrpA has now been well
established and an over-expression and purification protocol developed for extensive invitro biochemical characterization of wild-type and several engineered HrpA mutants.
Moreover, the ability to gently purify intact large complexes provides the ability to capture
HrpA from polysomal sucrose density gradient fractions to identify and quantify bound
RNAs or associated proteins.
With the potential that HrpA plays an unidentified role in translation of poly-proline
motifs, the designed dual luciferase poly-proline reporter combined with several of the
engineered HrpA mutants may be advantageous to test together. The two ATPase mutants,
due to the mechanistic substrate binding nature of some RNA helicases, are especially
useful for this type of in vivo reporter system. Moreover, it is possible there is more to be
learned from the initial mass spectrometry data produced from the dual luciferase reporter.
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Translation fidelity can be assessed with the peptides purified from strains that were prone
to production of truncated proteins. In the case of the poly-proline version of the dual
luciferase reporter, it may be interesting to take look further into the mass spectrometry
data for the Δefp ΔhrpA sample, considering it produced the most NanoLuc luciferase of
all the samples, even those with EF-P present.
Total RNA sequencing would provide a global approach as to how the
transcriptome shifts between wild-type, ΔhrpA, Δefp, and Δefp ΔhrpA cells, and how this
shift impacts the physiology, or vice versa, as cells lacking EF-P become healthier upon
the loss of HrpA. In addition, ribosome profiling (Ribo-Seq) can better characterize the
physiological shifts in these strains shedding light on how ribosomes are distributed across
messages in each strain’s given transcriptome. Previous physiological studies in Δefp cells
have been subjugated by the formation of fast-growing suppressors, obscuring results, and
most likely without the knowledge that this can occur [18]. Additionally, given that hrpA
is non-essential and ΔhrpA cells display no growth phenotype, a synthetic lethal screen can
be used to identify mutants that are dependent upon HrpA. Previous cloning and expression
experiments of hrpA have been successful, making complementation of hrpA under an
inducible promoter on an unstable plasmid feasible. This plasmid construct also coexpresses a cloned lacZ gene for use in blue/white screening. Cells are subjected to
chemical mutagenesis, plated on LB agar plates with IPTG and X-gal, and screened for
solid blue colonies. The unstable plasmid construct has a defective par locus which causes
defective partitioning during cell division. Cells that retain the plasmid in the absence of
antibiotic are dependent on the plasmid for growth, and therefore have a solid blue
phenotype (i.e. they are dependent on the expression of wild-type HrpA). Mutants can be
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isolated and the mutations identified using phage P1-mediated transduction mapping and
verified using Sanger sequencing.
Purified wild-type HrpA NTPase activity was tested with natural NTPs and nonhydrolyzable analogs and it was determined that HrpA can hydrolyze ATPγS but not
AMPPCP (data not shown). The ability to hydrolyze ATPγS is not of particular interest,
this is a feature common to other ATPases, however, incubating HrpA with the nonhydrolyzable AMPPCP analog may provide a useful mechanism for HrpA to bind
physiologically relevant substrates but not allow for dissociation. The bound RNAs can
then be purified and identified. Some RNA helicases will bind their substrates and begin
duplex strand separation, or unwinding, simply in the presence of an NTP, with the
subsequent hydrolysis step resulting in the release of the substrate and dissociation of the
helicase [38]. This characteristic may provide the ability to pull out HrpA substrates from
lysates of cells grown in the absence of HrpA.
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